doi:10.1001/jama.274.19.1526
While theres no direct evidence that IGF-1 causes cancer, it can theoretically accelerate the growth of existing or dormant tumors , especially in hormone-sensitive tissues like the breast, prostate, or colon
2 New classes of medications, such as the dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and sodium-glucose cotransporter- 2 (SGLT-2) inhibitors, specifically target some of the more recently identified defects described in the ominous octet to help manage uncontrolled hyperglycemia
It comes in an easy-to-use capsule form
Following the addition of DIP (1.80 g, 12.50 mmol, 50 eq), the reaction was allowed to proceed for an additional 12 h under identical conditions
[DOI] [PubMed] [Google Scholar] 111.Hanks T, Atkinson BL